...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: A couple Q2 events for Zenith

BDAZ - See post from 28 Feb 9:05pm

tada

Share
New Message
Please login to post a reply